These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5644 related items for PubMed ID: 15456102

  • 1. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 2. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C, Mouret P.
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [Abstract] [Full Text] [Related]

  • 3. [Venous thromboembolism prophylaxis after total hip arthroplasty].
    Kučera T, Malý R, Urban K, Sponer P.
    Acta Chir Orthop Traumatol Cech; 2011 Aug; 78(2):101-5. PubMed ID: 21575551
    [Abstract] [Full Text] [Related]

  • 4. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV, Howes J, Sharma V, Kadziola Z.
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [Abstract] [Full Text] [Related]

  • 5. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP, Bounameaux H.
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ, REGIMEN Investigators.
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low molecular weight heparin: a critical analysis of clinical trials.
    Green D, Hirsh J, Heit J, Prins M, Davidson B, Lensing AW.
    Pharmacol Rev; 1994 Mar; 46(1):89-109. PubMed ID: 8190751
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD, Johnson JA, Turpie AG.
    Arch Intern Med; 2004 Jun 28; 164(12):1319-26. PubMed ID: 15226166
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG, Lieberman JR.
    Am J Orthop (Belle Mead NJ); 2002 Sep 28; 31(9 Suppl):31-6. PubMed ID: 12349893
    [Abstract] [Full Text] [Related]

  • 15. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH, Muntz J.
    Clin Ther; 2009 Jun 28; 31(6):1129-41. PubMed ID: 19695383
    [Abstract] [Full Text] [Related]

  • 16. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug 28; 14(78):127-32. PubMed ID: 16106594
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R, Raskob G, Pineo G, Rosenbloom D, Evans W, Mallory T, Anquist K, Smith F, Hughes G, Green D.
    N Engl J Med; 1993 Nov 04; 329(19):1370-6. PubMed ID: 8413432
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S, Barbano B, Cianci R, Gigante A, Di Donato D, Asllanaj B, Dimko M, Mariotti A, Morabito S, Pugliese F.
    G Ital Nefrol; 2010 Nov 04; 27(6):649-54. PubMed ID: 21132647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 283.